Picture of Nanobiotix SA logo

NANO — Nanobiotix SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapSucker Stock

Brief: Nanobiotix Provides Says FY 2022 Net Loss Attributable To Shareholders Was EUR 1.64 Per Share

April 24 (Reuters) - Nanobiotix Sa  NANOB.PA :
    * NANOBIOTIX PROVIDES BUSINESS UPDATE AND REPORTS FULL YEAR
2022
FINANCIAL RESULTS
    * FY 2022 NET LOSS ATTRIBUTABLE TO SHAREHOLDERS WAS EUR 57.0
MILLION, OR EUR 1.64 PER SHARE
    * NO REVENUE WAS RECOGNIZED FOR YEAR ENDED DECEMBER 31, 2022
    * HAVE PREPARED OUR CONSOLIDATED FINANCIAL STATEMENTS
ASSUMING
THAT WE WILL CONTINUE AS A GOING CONCERN.
    * CO’S COVENANT OBLIGATIONS ENTAIL THAT CURRENT CASH & CASH
EQUIVALENTS ARE ONLY SUFFICIENT TO FUND OPERATING EXPENSES INTO
Q3 OF 2023

Source text for Eikon:  ID:nGNX2STvZs 
Further company coverage:  NANOB.PA 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Nanobiotix SA

See all news